Streetbeat News

Stock Prices

ELAN

Elanco's stock is rising following FDA approval for its new canine parasiticide, Credelio Quattro, which is administered monthly.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:21 pm

SOND

Sonder Holdings Inc. has received a Nasdaq Staff Determination Letter due to delinquent filings of its Forms 10-Q for Q1 and Q2 2024. The company risks suspension and delisting from Nasdaq unless it appeals by October 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:19 pm

AMZN

Amazon shares are down following a downgrade by Wells Fargo and a federal judge's decision to allow the FTC's antitrust lawsuit to proceed. Wells Fargo downgraded Amazon due to slowing growth and competition, while the FTC lawsuit alleges Amazon's monopolistic practices.

Portfolio Pulse from Adam Eckert

October 07, 2024 | 8:17 pm

IBM

The options market for IBM (NYSE:IBM) shows a bullish trend with 62 unusual trades, 59% of which are bullish. Significant investors are targeting a price range of $110 to $280. IBM's stock is currently up 0.5% at $227.12, with analysts maintaining positive ratings and target prices around $240-$250.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 8:15 pm

PTN

Palatin Technologies, Inc. has received a notice of non-compliance from NYSE American due to not meeting the stockholders' equity requirement of $6 million, as per Section 1003(a)(iii). This follows previous non-compliance under Sections 1003(a)(i) and (ii).

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:15 pm

SAM

Boston Beer Company has announced that its board has authorized an increase in the expenditure limit for its stock repurchase program by $400 million. This move indicates the company's confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:14 pm

RLI

RLI Corp. has announced estimated losses of $35M-$40M due to Hurricane Beryl and Hurricane Helene. This announcement may impact RLI's financial performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:11 pm

VINC

Vincerx Pharma shares rose following the release of initial clinical data from its VIP939 Phase 1 study, along with updates on its pipeline and corporate activities.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:07 pm

BDTX

Black Diamond Therapeutics is restructuring to focus on its BDTX-1535 program, leading to executive departures and a workforce reduction. The company aims to fund operations into Q2 2026 through cost savings.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:06 pm

MRM

MEDIROM Healthcare Technologies shares rose following the announcement of its acquisition of rehabilitation centers. The terms of the acquisition were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:06 pm